Presence of placental tissue is necessary for TNG to provide uterine relaxation.
Harnett
M J
MJ
Segal
S
S
D000328:Adult; D036861:Delivery, Obstetric; D005260:Female; D006801:Humans; D005996:Nitroglycerin / Q000627:therapeutic use*; D010120:Oxytocics / Q000627:therapeutic use; D010121:Oxytocin / Q000627:therapeutic use; D010920:Placenta / Q000502:physiology*; D018457:Placenta, Retained / Q000188:drug therapy / Q000503:physiopathology; D011247:Pregnancy; D014590:Uterine Contraction / Q000187:drug effects*; D019687:Uterine Inversion / Q000188:drug therapy; D014599:Uterus / Q000187:drug effects*; D014665:Vasodilator Agents / Q000627:therapeutic use*
D010120:Oxytocics; D014665:Vasodilator Agents; D010121:Oxytocin; D005996:Nitroglycerin